Implementation of OSPOP an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria

Computer Methods and Programs in Biomedicine

Volumn 50, Issue 1, 1996, Pages 13-22

  Tod, Michel ^a   Rocchisani, Jean Marie ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

Adaptive random search; API criteria; ED; EID; Optimal design; Population pharmacokinetics; Stochastic gradient

Indexed keywords

ADAPTIVE ALGORITHMS; COMPUTER SIMULATION; OPTIMIZATION; PARAMETER ESTIMATION; RANDOM PROCESSES;

ADAPTIVE RANDOM SEARCH; OPTIMAL SAMPLING TIMES; OSPOP ALGORITHM; STOCHASTIC GRADIENTS;

PHARMACOKINETICS;

METACYCLINE;

ALGORITHM; ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; DRUG DISPOSITION; HUMAN; HUMAN EXPERIMENT; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; SAMPLING; STOCHASTIC MODEL;

EID: 0030174935     PISSN: 01692607     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-2607(96)01721-X     Document Type: Article

References (15)

1. [1] E. M. Landaw, Optimal design for individual parameter estimation in pharmacokinetics, Variability in Drug Therapy: Description, Estimation and Control (Raven Press, New York, 1985).
2. [2] E.R. Carson, C. Cobelli and L. Finkelstein, The Mathematical Modelling of Biological and Endocrine Systems (Wiley-Interscience, New York, 1983).
3. [3] D.Z. D'Argenio, Optimal sampling times for pharmacokinetic experiments, J. Pharmacokinet. Biopharm. 9 (1981) 739-756.
4. [4] G.L. Drusano, A. Forrest, K.I. Plaisance and J.C. Wade, A prospective evaluation of OST in the determination of the steady-state pharmacokinetics of piperacillin in febrile neutropenic cancer patients, Clin. Pharmacol. Ther. 45 (1989) 635-641.
5. [5] G.L. Drusano, A. Forrest, M.J. Snyder, M.D. Reed and J.L. Blumer, An evaluation of optimal sampling strategy and adaptive study design, Clin. Pharmacol. Ther. 44 (1988) 232-238.
6. [6] L. Pronzato, E. Walter and C. Kulcsar, A dynamical-system approach to sequential design, in: Model Oriented Data Analysis, Physica-Verlag, Heidelberg, 1993, pp. 11-24.
7. [7] L. Pronzato and E. Walter, Robust experiment design via maximin optimization, Math. Biosci. 89 (1988) 161-176.
8. [8] L. Pronzato and E. Walter, Robust experiment design via stochastic approximation, Math. Biosci. 75 (1985) 103-120.
9. [9] E. Walter and L. Pronzato, Optimal experiment design for non-linear models subject to large prior uncertainties, Am. J. Physiol. 253 (1987) R530-R534.
10. [10] D.Z. D'Argenio, Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments, Math. Biosci. 99 (1990) 105-118.
11. [11] L. Pronzato, E. Walter, A. Venot and J.F. Lebruchec, A general-purpose global optimizer: implementation and applications, Math. Comput. Simulation 26 (1984) 412-422.
12. [12] W.H. Press, S.A. Teukolsky, W.T. Vetterling and B.P. Flannery, Numerical Recipes in C, 2nd edn., Cambridge University Press, 1992, pp. 1-993.
13. [13] L.B. Sheiner, Analysis of pharmacokinetic data using parametric models: regression models, J. Pharmacokinet. Biopharm. 12 (1984) 93-118.
14. [14] M. Tod, C. Padoin, K. Louchahi, B. Moreau-Tod, O. Petitjean and G. Perret, Application of optimal sampling theroy to the determination of metacycline pharmacokinetic parameters: effect of model misspecification, J. Pharmacokinet. Biopharm. 22 (1994) 129-146.
15. [15] J.L. Steimer, A. Mallet, J.L, Golmard and J.F. Boisvieux, Alternative approaches to estimation of pharmacokinetic parameters; comparison with the non-linear mixed effect model, Drug Metab. Rev. 15 (1984) 265-292.